✦ LIBER ✦

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence

✍ Scribed by Sandercock, J; Parmar, M K B; Torri, V; Qian, W

Book ID: 109997379
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 131 KB
Volume: 87
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600567

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

✍ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th

Phase II study of carboplatin followed b

Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer

✍ M. FRIEDLANDER; M. BUCK; D. WYLD; M. FINDLAY; B. FITZHARRIS; P. DE SOUZA; T. DAV 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Future options for first-line therapy of

Future options for first-line therapy of advanced ovarian cancer

✍ A. Du Bois; J Pfisterer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Is paclitaxel and cisplatin a cost-effec

Is paclitaxel and cisplatin a cost-effective first-line therapy for advanced ovarian carcinoma?

✍ Allan Covens; Sylvain Boucher; Kathie Roche; Moira Macdonald; Daniel Pettitt; Br 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

## BACKGROUND. Paclitaxel and cisplatin use for the treatment of advanced ovarian carcinoma (AOC) has been shown to increase median sunrival duration. An evaluation was performed on the economic consequences of treating AOC patients with combined paclitaxel and cisplatin chemotherapy compared with

First-line treatment of ovarian cancer F

First-line treatment of ovarian cancer FIGO stages IIb–IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

✍ G. B. Kristensen; I. Vergote; G. Stuart; J. M. Del Campo; J. Kaern; A. B. Lopez; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Improving first-line therapy of advanced

Improving first-line therapy of advanced ovarian cancer – the AGO Ovarian Cancer Study Group perspective

✍ A. Du Bois; J. Pfisterer; W. Meier; U. Wagner; for the ago Ovarian Cancer Study 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB